AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2021
May 3, 2021
30786_dirs_2021-05-03_9cc1cfa0-5288-4cf7-b105-9509880855d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-04-29
Reporting Person: RAMALINGAM AJIT (SVP, Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-29 | Bio-Rad A Common Stock | M | 276 | — | Acquired | 317.6638 | Direct |
| 2021-04-29 | Bio-Rad A Common Stock | F | 96 | $640.73 | Disposed | 221.6638 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-29 | Restricted Stock Units | $0 | M | 276 | Disposed | Bio-Rad A Common Stock (276) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 16.3100, 14.2312 and 11.1226 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2020, 12/31/2020, and 03/31/2021, respectively.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: On April 29, 2020, the reporting person was granted 1,384 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.